The University of Michigan Medical School has a long history of clinical, educational, and research collaboration with Chinese partners, both at the individual and the institutional level. More than 200 publications involving 50+ medical school faculty have been published with colleagues in China over the past few years, and almost twenty UMMS departments are currently collaborating with Chinese universities. Currently, the University of Michigan Medical School holds Memoranda of Understanding with the Chinese research and academic institutions: Peking Union Medical College, Peking University Health Science Center, and Shanghai Jiao Tong University.
On October 12, 2010 the Medical School´s global initiative took a major step forward when officials from the University of Michigan and Peking University Health Science Center (PUHSC) signed an unprecedented agreement to establish a Joint Institute for collaborative and translational research in specific diseases of interest to both institutions.
View list of Global REACH Faculty Associates collaborating in China here.
Joint Institute for Translational and Clinical Research
The Joint Institute for Translational and Clinical Research is a unique partnership between the University of Michigan Health System (UMHS) and PUHSC. The Joint Institute (JI) sponsors high-impact collaborative research that leverages the unique strengths of each university to advance global health.
The Joint Institute's research programs currently focus on four pervasive medical conditions: cardiovascular disease, liver disease, pulmonary disease, and renal disease. In each of these areas, panels of experts from both universities have identified promising clinical and translational research studies to be conducted jointly by teams at each university. Three infrastructure 'cores' support both the administrative and research aspects of the JI: Biorepository and Biomedical Informatics Core, Collaboration Core, and the IRB and Human Protection Core. Through this partnership, UMHS and PUHSC hope to enable scientists to translate basic research more quickly and efficiently into medical practice and improve outcomes for patients in the US, in China, and around the world.